Skip to content

Clinical trials

Phase 1 Inflammation trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 1 Clear all

197 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20045
20055
20065
20076
20089
200910
201010
201112
201213
201312
20146
20156
20168
20176
20189
20199
20206
202111
202210
20235
20246
202511
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed140
Recruiting17
Terminated17
Unknown status8
Withdrawn5
Active, not recruiting5
Not yet recruiting4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S10
GlaxoSmithKline6
National Eye Institute (NEI)5
National Institute of Mental Health (NIMH)5
University of California, Los Angeles5
Indiana University4
National Institute of Allergy and Infectious Diseases (NIAID)4
Sandoz4
Vanderbilt University4
Lebanese University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation197
Arthritis, Rheumatoid12
Atherosclerosis9
Pain9
Insulin Resistance8
Cardiovascular Diseases7
Neoplasms7
Asthma6
Diabetes Mellitus6
Diabetes Mellitus, Type 26

Trials

Showing 76 to 100 of 197. Each trial links to its page on Pharma Observatory.

97 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.